| ［1］ |
World Health Organization. Obesity and overweight [EB/OL]. WHO Website, 2025–12–08.
|
| ［2］ |
Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373–392.
|
| ［3］ |
国家卫生健康委员会. 中国居民营养与慢性病状况报告(2020年)[J]. 营养学报, 2020, 42(6): 521.
|
| ［4］ |
田沛荣, 张鹏. 减重与代谢手术研究进展[J]. 中华医学杂志, 2025, 105(37): 3337–3342.
|
| ［5］ |
李非, 张宗明. 消化道转流手术治疗2型糖尿病的研究进展[J]. 中华医学杂志, 2008, 88(38): 2733–2735.
|
| ［6］ |
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery[J]. Obes Surg, 2023, 33(1): 3–14.
|
| ［7］ |
Clapp B, Ponce J, Corbett J, et al. American Society for Metabolic and Bariatric Surgery 2022 estimate of metabolic and bariatric procedures performed in the United States[J]. Surg Obes Relat Dis, 2024, 20(5): 425–431.
|
| ［8］ |
国家卫生健康委员会. 肥胖症诊疗指南(2024年版)[J]. 中国循环杂志, 2025, 40(1): 6–30.
|
| ［9］ |
王勇, 王存川, 朱晒红, 等. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J]. 中国实用外科杂志, 2019, 39(4): 301–306.
|
| ［10］ |
曲伸, 陆灏, 宋勇峰. 基于临床的肥胖症多学科诊疗共识(2021年版)[J/OL]. 中华肥胖与代谢病电子杂志, 2021, 7(4): 211–226.
|
| ［11］ |
Burke E, Jenkins T, Boles RE, et al. Cognitive function 10 years after adolescent bariatric surgery[J]. Surg Obes Relat Dis, 2024, 20(7): 614–620.
|
| ［12］ |
Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: A review[J]. JAMA, 2020, 324(9): 879–887.
|
| ［13］ |
Qazi S, Ali H, Ansari H, et al. Effect of metabolic surgery on cardiovascular outcomes in people with obesity and pre-existing cardiovascular disease: A systematic review and meta-analysis[J]. Circulation, 2024, 150(Suppl 1): A4131100.
|
| ［14］ |
Aminian A, Zajichek A, Arterburn DE, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity[J]. JAMA, 2019, 322(13): 1271–1282.
|
| ［15］ |
Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity[J]. JAMA, 2018, 320(15): 1570–1582.
|
| ［16］ |
Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial[J]. Lancet, 2021, 397(10271): 293–304.
|
| ［17］ |
Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile[J]. Am J Cardiol, 2011, 108(10): 1499–1507.
|
| ［18］ |
Schiavon CA, Cavalcanti AB, Oliveira JD, et al. Randomized trial of effect of bariatric surgery on blood pressure after 5 years[J]. J Am Coll Cardiol, 2024, 83(6): 637–648.
|
| ［19］ |
Samarasinghe SNS, Leca B, Alabdulkader S, et al. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial[J]. Lancet, 2024, 403(10443): 2489–2503.
|
| ［20］ |
李坡, 陈文辉, 王存川, 等. 腹腔镜胃袖状切除术术后10年及以上结果的Meta分析[J]. 腹部外科, 2023, 36(5): 378–383.
|
| ［21］ |
朱江帆, 卢列盛. 腹腔镜胃袖状切除术：我们的做法与争议[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(1): 5–8.
|
| ［22］ |
陈文辉, 刘岩, 胡瑞祥, 等. 功能性袖状胃切除术: 一种新概念的减重手术方式[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(3): 163–169.
|
| ［23］ |
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 精准肥胖代谢外科手术中国专家共识(2022版)[J]. 中华胃肠外科杂志, 2022, 25(10): 841–851.
|
| ［24］ |
Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: A systematic review[J]. Obes Surg, 2013, 23(11): 1922–1933.
|
| ［25］ |
El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps-a scoping review[J]. Obes Surg, 2021, 31(4): 1755–1766.
|
| ［26］ |
Abu Dayyeh BK, Lautz DB, Thompson CC. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass[J]. Clin Gastroenterol Hepatol, 2011, 9(3): 228–233.
|
| ［27］ |
Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up[J]. Gastrointest Endosc, 2016, 83(4): 776–779.
|
| ［28］ |
Jirapinyo P, de Moura DTH, Thompson CC. Endoscopic submucosal dissection with suturing for the treatment of weight regain after gastric bypass: outcomes and comparison with traditional transoral outlet reduction (with video)[J]. Gastrointest Endosc, 2020, 91(6): 1282–1288.
|
| ［29］ |
Jirapinyo P, Kumar N, AlSamman MA, et al. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass[J]. Gastrointest Endosc, 2020, 91(5): 1067–1073.
|
| ［30］ |
Firkins SA, Sierra L, Khurana A, et al. Raising the BARS: first U. S. experience of a novel system for endoscopic gastrojejunal anastomosis revision[EB/OL]. Tech Innov Gastrointest Endosc, 2025, 250944[2026–04–08].
|
| ［31］ |
Saumoy M, Schneider Y, Zhou XK, et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty[J]. Gastrointest Endosc, 2018, 87(2): 442–447.
|
| ［32］ |
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial[J]. Lancet, 2022, 400(10350): 441–451.
|
| ［33］ |
Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, et al. Efficacy and safety of endoscopic sleeve gastroplasty: A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2020, 18(5): 1043–1053, e4.
|
| ［34］ |
Kotinda A, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: A systematic review and meta-analysis of randomized controlled trials[J]. Obes Surg, 2020, 30(7): 2743–2753.
|
| ［35］ |
Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: A systematic review and meta-analysis[J]. Obes Surg, 2020, 30(8): 3010–3029.
|
| ［36］ |
Daniel L, Qiuye C, Sam A, et al. 胃内球囊术治疗不同体质量指数肥胖症的短期临床疗效[J]. 中华消化外科杂志, 2022, 21(12): 1573–1578.
|
| ［37］ |
康军仁, 徐强, 李海龙, 等. 胃内球囊用于减重的临床研究进展[J]. 协和医学杂志, 2023, 14(3): 591–597.
|
| ［38］ |
周华梅, 吴晓颖, 张毅. 十二指肠黏膜表面重建术治疗2型糖尿病的研究进展[J]. 国际内分泌代谢杂志, 2022, 42(2): 146–149.
|
| ［39］ |
Mingrone G, van Baar AC, Devière J, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial[J]. Gut, 2022, 71(2): 254–264.
|
| ［40］ |
Liu Yan. iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss(iWAIST-RCT)[C/OL]. NLM identifier: NCT07237750. 2025–11–20.
|
| ［41］ |
中华医学会消化内镜学分会胃病学组. 内镜下十二指肠-空肠旁路套管置入术减重专家建议(2025版)[J]. 中华消化内镜杂志, 2025, 42(7): 509–512.
|
| ［42］ |
Stratmann B, Krepak Y, Schiffer E, et al. Beneficial metabolic effects of duodenal jejunal bypass liner for the treatment of adipose patients with type 2 diabetes mellitus: analysis of responders and non-responders[J]. Horm Metab Res, 2016, 48(10): 630–637.
|
| ［43］ |
中华医学会消化内镜学分会微创减重治疗协作组, 中国医师协会消化医师分会减重专业委员会, 国家消化系统疾病临床医学研究中心(北京). 中国肥胖症消化内镜治疗专家共识[J]. 中华消化内镜杂志, 2024, 41(1): 1–10.
|
| ［44］ |
Patel N, Mohanaruban A, Ashrafian H, et al. EndoBarrier®: A safe and effective novel treatment for obesity and type 2 diabetes?[J]. Obes Surg, 2018, 28(7): 1980–1989.
|
| ［45］ |
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity[J]. N Engl J Med, 2022, 387(3): 205–216.
|
| ［46］ |
Nadolsky KZ, Agarwal M. Once-weekly semaglutide in adults with overweight or obesity[J]. N Engl J Med, 2021, 385(1): e4.
|
| ［47］ |
Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3. 0 mg of liraglutide in weight management[J]. N Engl J Med, 2015, 373(1): 11–22.
|
| ［48］ |
Velji-Ibrahim J, Radadiya D, Devani K. Comparative efficacy and safety of bariatric surgery, bariatric endoscopy, and GLP-1 receptor agonists in obesity management: A network meta-analysis[J]. Am J Gastroenterol, 2024, 119(10S): S1472–S1473.
|
| ［49］ |
Ghusn W, Divakar A, Salameh Y, et al. Emerging trends in endoscopic bariatric therapies: personalization through genomics and synergistic pharmacotherapy[J]. J Clin Med, 2025, 14(13): 4681.
|
| ［50］ |
de Waal JR, Nieuwdorp M, Gerdes VEA. The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: A narrative review[J]. Front Endocrinol (Lausanne), 2026, 17: 1680182.
|
| ［51］ |
Sharaiha RZ, Hajifathalian K, Kumar R, et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity[J]. Clin Gastroenterol Hepatol, 2021, 19(5): 1051–1057, e2.
|
| ［52］ |
中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2023年度报告[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(2): 73–83.
|
| ［53］ |
中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 等. 袖状胃切除术患者胃食管反流病诊治中日韩专家上海共识(2024版)[J]. 中华消化外科杂志, 2024, 23(9): 1140–1157.
|
| ［54］ |
Akwe J, Fongeh K, Jung S, et al. Medical vs surgical obesity management: A narrative review of efficacy, safety, and long-term outcomes[J]. Cureus, 2025, 17(9): e91677.
|